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mortality rates and important economic 
repercussions with an estimated total 
direct cost of  approximately 2 billion 
dollars in 1998 in US hospitals alone (14). 
Even treatments using available antifungal 
agents, mortality rates lie in the 30-50% 
range for these infected patients (13). 
Although several other Candida species 
are also human pathogens that have 
been found with increasing frequency, C. 
albicans remains by far the most medically 
important member of  the genus (7). 
C. albicans can transition between 
yeast cells, psuedohyphae or hyphae. 
Filamentation of  yeast cells to hyphal 
growth is directly linked to its pathogenicity 
and cells that cannot make the transition 
are known to be avirulent. C. albicans is 
known to form chlamydospores when 
low levels of  nutrients comprise its 
environment. Chlamydospores are thick-
walled, spherical cells that are three to 
four times larger than normal yeast cells 
and are produced from suspensor cells at 
the end of  what are likely pseudohyphal 
elements ([10] Figure 1).    
Introduction
Candida albicans exists and thrives 
on mucosal surfaces of  the gastrointestinal 
tract and urogenital tract in healthy 
persons, but it can also cause severe and 
life-threatening infections, especially 
in immunocompromised patients (4), 
and thus has become a relevant topic in 
the medical community. A wide range 
of  factors leads to various degrees of  
immunosuppression that predispose 
patients to infection by Candida. These 
factors include a severe underlying disease 
(e.g., AIDS or leukaemia), impaired 
phagocytic function (i.e., granulocytopenia 
or neutropenia), and exogenous factors 
(e.g., wide spectrum antibiotic treatment, 
i.v. drug use, transplantation medicine, 
trauma, abdominal surgery [5]). Also, 
candidiasis, a systemic yeast infection, 
now represents the third to fourth most 
frequent hospital acquired infection in 
the US and worldwide, and C. albicans 
remains the most frequent causative 
agent of  candidiasis (1). These infections 
carry unacceptably high morbidity and 
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Figure 1: Chlamydospore formation of  C. albicans
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affected differently from the filamentation 
pathway, as seen by the control effects of  
SSY50b (Fig. 2).
Analysis of  dependency of  NRG1 
in chlamydospore formation. In 
order to determine whether the association 
of  NRG1p and Tup1p is involved in the 
development of  chlamydospores in C. 
albicans, we used two types of  media. 
Using staib agar, which is known to stifle 
chlamysdospore formation in C. albicans 
but not in C. dubliniensis, we created one 
plate with the addition of  doxycycline and 
the other plate without. Since comparisons 
of  C. albicans and C. dubliniensis have been 
found to regulate NRG1p differently (12), 
we took advantage of  the wild-type strains 
SC5314 (C. albicans) and C. dubliniensis 
as controls to our variable strains DPTY2 
(∆NRG1/tet-NRG1), SSY50b (NRG1/
tet-NRG1) and ICY49 (∆Tup1/∆Tup1). 
Another way we controlled the experiment 
was to use a nutrient-poor media, Rice 
Tween 80 agar, in a candle jar to limit 
the oxygen availibility, which supports 
chlamydospore formation in C. albicans. 
The RTW plates were made with and 
without doxycycline. 
Each strain was innoculated onto the 
plain Staib and RTW plates, with the tet-
regulateable strains DPTY2 and SSY50b 
added to the doxycycline plates. All 
cultures were grown at 28ºC in darkness 
for 14 days. Comparison assessments were 
documented via microscopy at 48 hours, 7 
days and 14 days (Fig. 3). 
In the Staib agar, we were able to 
induce chlamydospore formation in C. 
albicans that is indistinguishable from 
the C. dubliniensis wild-type. However, 
for SSY50b, which has one regulateable 
allele of  NRG1 and one wild-type allele, 
we were unable to induce chlamydospore 
formation. SSY50b acts the same as 
SC5314 (wild-type), which grows a neglible 
amount of  chlamydospores (1-5% 10µL-1). 
This data shows that expression of  NRG1 
has a significant negative repression on 
chlamydospore formation in C. albicans, 
and when it is inhibited, chlamydospore 
formation is induced. 
If  TUP1 is a crucial binding partner 
to NRG1 to induce chlamydospore 
formation, deleting the gene should show 
similar results to the complete repression 
of  NRG1. Our results show the contrary. 
ICY49 (∆tup1/∆tup1).
Culture media and growth 
conditions for preparation of  
RNA analysis. All strains were grown 
overnight in liquid YPD (yeast, peptone, 
dextrose media) at 28ºC. Cultures were 
then washed with phosphate buffered 
NaCl (PBS) x 2 (as described by Jansons 
and Nickerson, [6]). Various dilutions of  
each strain yeilded a cell count of  10¬¬6/
mL. A 20:1 diluted subculture of  each 
strain was added to liquid Staib media 
(syn. Guizotia abyssinica, creatinine, 
glucose, KH2PO4¬), (12). In addition, two 
subcultures of  DPTY2 and SSY50b were 
made, one with the tetracycline analog, 
doxycycline, and the other without. These 
cultures were then grown at 32ºC for 48 
hours in a shaking water bath. 
RNA isolation was achieved with our 
adapted methodology and the Masterpure 
yeast isolation kit (Epicentre™). 1µg of  this 
RNA was used to generate cDNA using the 
first strand synthesis kit (Five-prime™), and 
the cDNA was quantitatively compared 
by real-time PCR using GoTaq™ Sybr™ 
green (Promega™) on an Mx3000P real-
time machine (Stratagene™). The relative 
expression of  the ACT1 (actin) gene was 
used to normalize the data across samples. 
Culture media and growth 
conditions for NRG1/Tup1 
association assay. Initial steps up to 
and including PBS wash were the same as 
above. Each strain was inoculated to plates 
of  Staib agar, with and without doxycycline 
and Rice Tween 80 agar (RTW), with 
and without doxycycline. RTW plates 
were housed in a candle jar. Plates were 
incubated at 28ºC, in darkness, for 14 days. 
Cultures were analyzed by microscopy at 
48 hours, 7 days and 14 days. 
Results
Analysis of  genetic expression 
of 	 Hyphal	 Specific	 Genes	 in	 tet-
regulated NRG1 strains. Quantitative 
real-time PCR analysis of  DPTY2 and 
SSY50b, with and without doxycycline, 
reveals a difference in expression of  
the major hyphal-specific genes on 
chlamydospore formation. This data 
shows that when complete repression of  
NRG1 (DPTY2) occurs within the first 
48hrs, the major hyphal-specific genes are 
Because chlamydospores arise in 
conditions of  nutrient depletion, they are 
believed to be dormant growth forms that 
can be induced to germinate by changing 
environmental conditions (6).
Chlamydospore-like structures have 
been detected occasionally in the human 
host, however, whether chlamydospores 
contribute to colonization or pathogenicity 
of  C. albicans is unknown (4). Examining 
the regulation of  the gene NRG1p and its 
direct relationship to filamentation (hyphal 
growth) and chlamydospore formation, will 
contribute greatly to the understanding of  
this virulence factor of  C. albicans and 
what its biological role is. This study aims 
to fill in the gaps in our understanding 
of  the mechanisms which underpin this 
important biological phenomenon, the 
genetic regulation of  chlamydospore 
formation in relation to filament formation. 
The gene NRG1 is a known inhibitor, or 
repressor, of  the Hyphal Specific Genes 
(HSG) and has been strongly implicated 
in chlamydospore formation. It has 
been shown that differential regulation 
of  the single gene NRG1 in C. albicans 
and (closely related species) Candida 
dubliniensis is responsible for their species-
specific response to environmental signals 
that induce chlamydospore development 
(12). Furthermore, morphogenesis (yeast 
to psuedohyphal/hyphal transition) is 
repressed by transcriptional inhibitors such 
as Tup1p, which associates with its DNA-
binding partners NRG1p and Rfg1p (3). 
However, the nature by which this gene is 
regulated is in question; thus, in this study 
we intended to investigate (1) the hyphal 
specific genes regulated in chlamydospore 
formation and (2) the necessity or 
dependency of  coupling with the gene 
TUP1 during chlamydospore formation.
Materials and Methods
Strains. A comparison of  four C. 
albicans strains and one C. dubliniensis 
strain were used. C. albicans wild-type 
strain SC5314 was used as a control along 
with C. dubliniensis wild-type strain. 
These strains were chosen based on their 
known performance in Staib medium, as 
published by Staib and Morschhäuser. 
Comparison strains used were C. albicans 
strains DPTY2 (NRG1/NRG1 tet-NRG1), 
SSY50b (∆NRG1/NRG1 tet-NRG1), and 
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When ICY49 is grown in the same 
conditions described above on Rice Tween 
80 agar plus doxycycline, chlamydospore 
formation is no more significant than the 
wild-type expression of  SC5314. This 
leads to the conclusion that TUP1 is not 
a significant participant in chlamydospore 
formation. Further investigations will focus 
on if  NRG1 alone regulates chlamydospore 
formation or if  it binds with any other gene 
during this regulation.
Figure 2: Differential expression of  hyphal specific genes on NRG1p
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